Author: administrator

Granular View of the Leukocytapheresis Device Market from Various End-Use Segments 2021 – 2028

Post author By administrator
Post date October 8, 2021
No Comments on Granular View of the Leukocytapheresis Device Market from Various End-Use Segments 2021 – 2028

A recent study on the Leukocytapheresis Device Market presents data-driven expert insights and various opportunity assessment frameworks for stakeholders. The business intelligence report on the various growth dynamics of the Leukocytapheresis Device market helps interested market participants to chart possible evolution trajectories during the forecast period. The study is prepared after completing several rounds of primary research and making extensive secondary research.

The analysts or the authors of the study have strived to offers critical scrutiny of the changing vendor landscape, recent macroeconomic upheavals that affect consumer sentiment, and the overall competitive dynamics. The account on the growth dynamics of the Leukocytapheresis Device market makes a detailed as well as in-depth segmentation to understand the current opportunities and emerging avenues.

In particular, the expert assessment on the emerging growth dynamics offers methods and frameworks for industries, policymakers, and investors to understand the current and emerging avenues in the Leukocytapheresis Device market. The frameworks offered to facilitate decision making for stakeholders on comprehending the essence of the value chain, and the possibilities that end-use industries offer to the Leukocytapheresis Device market.

Get Request for PDF Brochure of This Market Research Report @ https://www.factmr.com/connectus/sample?flag=B&rep_id=1113

The market analysts and the opinion leaders who have collaborated in offering insights into the growth prospects in the Leukocytapheresis Device market. Of note, the assessment aims at expanding the understanding of various elements of marketing and supply chains in the currently emerging COVID-era. The new business models and their attractiveness are scrutinized in the new study on the Leukocytapheresis Device market.

Some of the new approaches that Fact.MR report analysts strive for analyzing the dynamics of the Leukocytapheresis Device market can be summed as:

The analysts try to decode the hype and the facts that surround the consumer sentiment in the Leukocytapheresis Device market
The report offers the recent disruptions caused by the COVID-19 pandemic and the emergence of new digital models in the Leukocytapheresis Device market
A multidimensional assessment of the key government regulations
The recent changes of the outlook of the policymakers of various key countries
Workplace diversity that are shaping the strategic realignments
Limitations of the evaluation of prevalent consumer preferences

The research presents a comprehensive insight into the competitive dynamics and detailed profiling of various industry players. Some of the top players in the Leukocytapheresis Device market are:

Asahi Kasei Medical Co., Ltd., JIMRO Co. Ltd.

GLOBAL LEUKOCYTAPHERESIS DEVICE MARKET SEGMENTATIONS

The global Leukocytapheresis devices market is segmented on the basis of product type, end user and geography.

Based on product type, leukocytopheresis devices market is segmented into:

Adacolumn
Cellsorba

Based on end user, Leukocytapheresis devices market is segmented into:

Hospitals
Specialty Clinics
Ambulatory Surgical Centers

The Leukocytapheresis Device Market report provides estimations and the market sizing and prospects of various regions. To this end, the study makes in-depth segmentation of the following key regions:

North America (U.S. and Canada)
Latin America (Mexico, Brazil, Peru, Chile, and others)
Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
Eastern Europe (Poland and Russia)
Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
Middle East and Africa (GCC, Southern Africa, and North Africa)

Get Request for Report Customization @ https://www.factmr.com/connectus/sample?flag=RC&rep_id=1113

Some of the insights and trends that help understand the imminent investment pockets in the Leukocytapheresis Device market are mentioned below:

Investment trends of top industry stakeholders
Strategies adopted by businesses in various industries that shape the demand in the Leukocytapheresis Device market
Mission-critical priorities that will gain attention among prominent players in the Leukocytapheresis Device market
Share of the leading regional markets in the global Leukocytapheresis Device market
Size of opportunities in emerging regional markets
New avenues in various product segments
New business models that will gather traction in the near future
The game-changing potential that some of the recently unveiled technologies have
Patents and research investments that may change the course of the Leukocytapheresis Device market
End-use industries where the demand may gain rapid traction

The detailed assessments focus on, inter alia, on the regulatory and macroeconomic frameworks, prevailing pricing structure, imminent investment pockets, and emerging application areas. Taking the analysis further, the study helps readers get a better understanding of the trends characteristics of the emerging markets, including government regulations crucial to growth of such markets. Shares of major regional markets are also presented in the analysis.

The report offers insight into the competitive dynamic in the Leukocytapheresis Device market which has shaped the major strategies of each player. It also covers recent moves such as partnerships and collaborations, mergers and acquisitions, diversification and research investments, of each prominent player. The key factors that shape the entry barrier and intensity of competition in the Leukocytapheresis Device market are presented in the analysis. Further, the study provides PESTLE analyses of numerous players and an evaluation of how the competitive landscape will evolve over the forecast period.

Enquiry before Buying @ https://www.factmr.com/connectus/sample?flag=EB&rep_id=1113

Relevant Takeaways from Report:

Marketing and promotional strategies adopted by prominent market players
Historic, current, and projected valuation of the Leukocytapheresis Device market
Overview of the regulatory framework governing the different aspects of the Leukocytapheresis Device market
Recent advancements in the Leukocytapheresis Device market landscape
In-depth analysis of the different segments of the Leukocytapheresis Device market

After reading the Leukocytapheresis Device market report, readers can:

Understand the drivers, restraints, opportunities and trends affecting the growth of the global Leukocytapheresis Device market.
Analyze key regions holding significant share of the total Leukocytapheresis Device market revenue.
Study the growth outlook of the global Leukocytapheresis Device market scenario, including production, consumption, history and forecast.
Learn consumption pattern and impact of each end use on the Leukocytapheresis Device market growth.
Investigate the recent R&D projects performed by each Leukocytapheresis Device market player.

More Related Reports By Fact.MR On Healthcare Domain:

Ophthalmic Eye Shield Market Forecast, Trend Analysis & Competition Tracking – Global Market insights 2018 to 2028

Vaginal Rejuvenation Market Forecast, Trend Analysis & Competition Tracking – Global Market insights 2018 to 2028

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analysed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),

Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers,

Dubai, United Arab Emirates

Email: sales@factmr.com

Visit Our Website: https://www.factmr.com

Tags COVID-19 Analysis, Forecast, Growth, Leukocytapheresis Device Market, Market Analysis, Review, Share, Size, Trends

Pharmaceutical

Antimicrobial Susceptibility Test Market 2025 (Covid-19 Analysis) Major Factors That Can Increase The Worldwide Demand

Post author By administrator
Post date October 8, 2021
No Comments on Antimicrobial Susceptibility Test Market 2025 (Covid-19 Analysis) Major Factors That Can Increase The Worldwide Demand

Opportunities for players in the antimicrobial susceptibility test market are likely to arise from increasing public-private partnerships in the healthcare sector. These partnerships are intended to encourage the free flow of finance for the development of effective products. Despite this financial lucidity, the high development cost of testing kits, given the complexity and tedious nature of testing, could adversely impact returns on investment of manufacturers.

For detailed insights on enhancing your product footprint, request for a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=4334

Diagnostic laboratories and hospitals are projected to remain crucial end users, and a substantial chunk of product sales will close from the clinical diagnosis of bacteria, fungi, and parasites. Given the impact of numerous dynamics recorded in an exclusive study published by Fact.MR, the antimicrobial susceptibility test market is projected to record year-over-year growth of 6.5% in 2020, over 2019.

Key Highlights of Antimicrobial Susceptibility Test Market Study

Ease of sample processing through the use of advanced lab instruments and better turnaround time of samples are projected to create a large patient pool for diagnosis, which, in turn, will amplify the demand for antimicrobial susceptibility test kits during the forecast period.
Online sales channels are emerging as an integral revenue stream for the antimicrobial susceptibility test market. These channels are being leveraged by key vendors to disseminate brand information and gain access to local markets.

For critical insights on this market, request for methodology here – https://www.factmr.com/connectus/sample?flag=RM&rep_id=4334

Initiatives taken by central health authorities are projected to draw consumers’ attention towards the importance of antibiotics. For instance, WHO observes a week in November as World Antibiotic Awareness Week (WAAW), to inspire the best clinical practices among health workers and policymakers in order to control antibiotic resistance.
Introduction of advanced antimicrobial susceptibility tests, which offer results in around 2 hours, sets the standards for better patient outcomes. For instance, FASTinov announced the launch of a rapid antimicrobial susceptibility test, which is based on flow cytometry, to offer clinically-implementable results in as little as two hours. Such advancements are likely to inspire the development of effective test products.

A senior market research analyst at Fact.MR opines that– “An entry into the antimicrobial susceptibility test market is highly capital-intensive, as CAPEX includes the cost of sophisticated equipment and skilled labor. In addition, capital becomes an essential fuel to foster R&D activities, which could create an entry barrier for new players in the antimicrobial susceptibility test market.”

Developing Regions Hold High RoI Potential over Developed Regions

The shift from traditional testing methods to new ones is underway – albeit at a slow pace – in developing countries. Players in the antimicrobial susceptibility test market can exploit this opportunity to move their operational facility to these regions to lower overhead costs and close profitable deals. Regulations regarding product development are relatively lenient in these countries, which further draws the attention of global market players operating in developed countries.

For in-depth competitive analysis, buy now – https://www.factmr.com/checkout/4334

For instance, bioMerieux SA announced an alliance with Merieux NutriSciences, and launched VITEK express identification services in the U.S., Spain, and Italy. In addition, Bio-Rad Laboratories, Inc. announced a partnership with Illumina, Inc. for the development of a comprehensive next-gen sequencing workflow for single-cell analysis. Besides these developments, players in the antimicrobial susceptibility test market are magnifying their focus on the production of biologics-based therapeutics and vaccines, and this is projected to remain crucial for achieving better patient outcomes and higher recovery rates.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Landscape

Wound Tissue Analysis Solutions Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028- https://www.factmr.com/report/2189/wound-tissue-analysis-solutions-market

Wireless Neurostimulator Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028- https://www.factmr.com/report/2188/wireless-neurostimulator-market

Skin Cooling Systems Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028- https://www.factmr.com/report/2186/skin-cooling-systems-market

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Tags Antimicrobial Susceptibility Test Market, Antimicrobial Susceptibility Test Market Analysis, Antimicrobial Susceptibility Test Market Demand, Antimicrobial Susceptibility Test Market Estimate, Antimicrobial Susceptibility Test Market Forecast, Antimicrobial Susceptibility Test Market Insights, Antimicrobial Susceptibility Test Market Scope, Antimicrobial Susceptibility Test Market Share, Antimicrobial Susceptibility Test Market size, Antimicrobial Susceptibility Test Market Statistics, Antimicrobial Susceptibility Test Market Trends

Pharmaceutical

Demand for Intraoperative MRI Equipment Market to Expand at a CAGR of 7.5% Through 2026

Post author By administrator
Post date October 8, 2021
No Comments on Demand for Intraoperative MRI Equipment Market to Expand at a CAGR of 7.5% Through 2026

Traditional image-guided procedures remained restricted to the limitation of physicians referring to pre- and post-operative images for conducting neurosurgical or maxillofacial procedures. With advancements in medical imaging technologies, intraoperative MRI techniques paved their way in the diagnosis-guided surgery landscape, enabling physicians and surgeons to view the images during surgery, rather than referring to them preoperatively or postoperatively. Advanced intraoperative MRI equipment are being developed to facilitate enhanced imaging for physicians and lower the risks of improper surgeries during preoperative conditions.

For detailed insights on enhancing your product footprint, request for a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=519

Fact.MR observes as robust growth in demand for intraoperative MRI equipment in the global healthcare marketplace. By the end of 2026, the global intraoperative MRI equipment market is estimated to surpass US$ 315 million valuation. The advantage of intraoperative MRI equipment in improving the localization for physicians during surgeries will continue to bolster their demand in the near future. During the period, 2017-2026, the global market for intraoperative MRI equipment is assessed to reflect a CAGR of 7.1% in terms of volume.

The Uptake for Intraoperative MRI Equipment to Remain High in Medical Communities

As the years progress, advancements in medical imaging technologies are being welcomed by communities of physicians and surgeons across the globe. Currently, the adoption of intraoperative MRI equipment showcases a promising growth. Leading medical research organizations are exhibiting readiness to invest in technologies for instrumenting developments in the operability and functioning of intraoperative MRI equipment. Multiple advantages of using intraoperative MRI equipment will be driving their uptake in the coming years.

Real-time visualization offered by latest intraoperative MRI equipment to improve the efficiency of surgical interventions
Gradient-imaging advantage of intraoperative MRI equipment to support physicians in planning the path of surgery
Cost-effective maintenance to compensate for high prices of intraoperative MRI equipment
The co-efficiency of intraoperative MRI equipment in lowering the chances of second surgical intervention to aid patient outcomes of hospitals

For critical insights on this market, request for methodology here – https://www.factmr.com/connectus/sample?flag=RM&rep_id=519

Furthermore, intraoperative MRI equipment operate on conventional MRI modality, which supplements their adaptability among traditional healthcare settings. It has been estimated that majority of intraoperative MRI equipment manufactured in the world will be adopted by hospitals. Sufficient funding to purchase these expensive machines will keep hospitals at the forefront of global intraoperative MRI equipment end-use. By the end of 2026, more than 2,200 units of intraoperative MRI equipment are expected to be sold across hospitals worldwide.

North America – Largest Market for Intraoperative MRI Equipment through 2026

The report estimates that majority of intraoperative MRI equipment are produced and sold in the US. High value growth in North America’s medical tourism sector will drive the sales of intraoperative MRI equipment in the US and Canada. Companies such as Medtronic Plc, GE Healthcare, IMRIS, Inc., Siemens AG, Hitachi Corporation, and Koninklijke Philips N.V., which are the key players in global intraoperative MRI equipment market are prominent in the US and have gained their footholds across Europe and the Asia-Pacific excluding Japan (APEJ) region.

For in-depth competitive analysis, buy now – https://www.factmr.com/checkout/519

In the coming years, a steady demand for 0.2T systems will be observed in the global intraoperative MRI equipment landscape. Growing need for low-field MRI in surgical interventions will drive the demand for 0.2T systems across the globe. The report also estimates that 3.0T systems will register a rapid growth in terms of volume, reflecting a 9% CAGR over the forecast period. Manufacturers will continue to extend the production of these two key systems to capture the specific demands of physicians. Moreover, lowering the risks of these systems in creating geometrical distortion will be prioritized by intraoperative MRI equipment manufacturers in the foreseeable future.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Landscape

Wireless Neurostimulator Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028- https://www.factmr.com/report/2188/wireless-neurostimulator-market

Skin Cooling Systems Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028- https://www.factmr.com/report/2186/skin-cooling-systems-market

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Tags Intraoperative MRI Equipments Market, Intraoperative MRI Equipments Market Analysis, Intraoperative MRI Equipments Market Demand, Intraoperative MRI Equipments Market Estimate, Intraoperative MRI Equipments Market Forecast, Intraoperative MRI Equipments Market Insights, Intraoperative MRI Equipments Market Scope, Intraoperative MRI Equipments Market Share, Intraoperative MRI Equipments Market Size, Intraoperative MRI Equipments Market Statistics, Intraoperative MRI Equipments Market Trends

Pharmaceutical

Europe to be the Most Attractive Market for Stent Graft Balloon Catheter Through 2022

Post author By administrator
Post date October 8, 2021
No Comments on Europe to be the Most Attractive Market for Stent Graft Balloon Catheter Through 2022

The global stent graft balloon catheter market will register a healthy expansion during 2017 to 2022. Revenues from the market are expected to surpass US$ 1,000 Mn by the end of 2022.

Usually utilized in bypass graft surgery as well as balloon angioplasty, stent graft balloon catheters prevent risks concerning occurrence of re-narrowing in patients undergoing angioplasty, and risks related to abrupt artery closure. Owing to these advantages offered by stent graft balloon catheters, their demand is witnessing a rise.

For detailed insights on enhancing your product footprint, request for a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=149

A gradual evolution has been observed in the stent graft balloon catheter market, from the simple stents to modification of balloon stent catheters. Since recent past, there has been a surge in hospital admissions caused by increasing cases of atherosclerosis, and soaring prevalence of CAD – coronary artery disease globally. Numerous developments have been realized in technology of balloon catheters, along with the hike in healthcare expenditure. These factors are expected to augment growth of the market. In contrast, high prices of angioplasty procedures has become a problem for population across developing and underdeveloped economies. This might act as an impeding factor for the market growth.

Growth of the global stent graft balloon catheter market has been highly favored by the advent of drug eluting balloons. In addition, shifting preferences towards using balloons with drug delivery, and helping to deliver medications at local sites, has deemed them to be effective substitutes for administering drugs intravenously.

For critical insights on this market, request for methodology here – https://www.factmr.com/connectus/sample?flag=RM&rep_id=149

Various new products developed are being approved for treatment of vascular diseases. For instance – recently, the FDA has approved use of expandable balloon stent graft introduced by the W.L. Gore & Associates to treat peripheral artery disease. Moreover, technology advancements in the stent graft balloon catheters, coupled with increasing awareness about angioplasty, and sophisticated healthcare infrastructure in developed economies are further poised to drive the market growth in the near future.

9 Key Estimations from Fact.MR’s Report on the Global Stent Graft Balloon Catheter Market

Based on raw material, sales of polyurethane for producing stent graft balloon catheters will register a steady expansion, while sales of nylon are estimated to register a sluggish growth through 2022.
Cardiac catheterization laboratories are anticipated to become the fastest growing end-users in the global stent graft balloon catheter market.
Ambulatory surgical centres are expected to be the least lucrative end-users of stent graft balloon catheters.
Hospitals will continue to be the largest end-user segment, with sales poised to reach nearly US$ 900 Mn by 2022-end.
Sales of stent graft balloon catheters for coronary artery disease indication are projected to account for over two-third share of the market over the forecast period, in terms of revenues.

For in-depth competitive analysis, buy now – https://www.factmr.com/checkout/149

Demand for stent graft balloon catheters from peripheral vascular disease indication segment will remain sluggish in the market.
Although, the market in Middle East & Africa (MEA) is expected to register a sluggish expansion, sales of stent graft balloon catheter in this region are estimated to gain an uptick by 2022-end.
Europe will continue to be the largest market for stent graft balloon catheter, with sales projected to exceed US$ 400 Mn in revenues by 2022-end.
Key players contributing to growth of the market include Meril Life Sciences Pvt. Ltd., Abbott Laboratories, Hexacath, Cardionovum GmbH, Jotech GmbH, MicroPort Scientific Corporation, Boston Scientific Corporation, Terumo Corporation, Cook Medical INC, B. Braun Melsungen AG, Cordis Corporation, and Medtronic Plc.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Landscape

Wireless Neurostimulator Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028- https://www.factmr.com/report/2188/wireless-neurostimulator-market

Skin Cooling Systems Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028- https://www.factmr.com/report/2186/skin-cooling-systems-market

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Tags Stent Graft Balloon Catheter Market, Stent Graft Balloon Catheter Market Analysis, Stent Graft Balloon Catheter Market Demand, Stent Graft Balloon Catheter Market Estimate, Stent Graft Balloon Catheter Market Forecast, Stent Graft Balloon Catheter Market Insights, Stent Graft Balloon Catheter Market Scope, Stent Graft Balloon Catheter Market Share, Stent Graft Balloon Catheter Market Size, Stent Graft Balloon Catheter Market Statistics, Stent Graft Balloon Catheter Market Trends

Pharmaceutical

Global eCOA, eSource & Clinical Trials Market: Emerging Economies Expected to Influence Growth until 2029

Post author By administrator
Post date October 8, 2021
No Comments on Global eCOA, eSource & Clinical Trials Market: Emerging Economies Expected to Influence Growth until 2029

The latest Fact.MR study indicates healthcare facilities, contract research organizations, and educational & research institutes collectively spent ~US$ 1,950 Mn on eCOA, eSource and clinical trials solutions in 2018. The eCOA, eSource & clinical trials market is envisaged to witness substantial traction through 2019, with gains primarily driven by the growing penetration of digitization in healthcare sector and substantial increase in pharma spending on clinical trials.

Rapidly expanding deployment of clinical trial solutions, which contributed to ~40% of the total spending on eCOA, eSource, and clinical trials in 2018, will continue to appeal a widening bandwidth of institutions through 2029, says the report.

For detailed insights on enhancing your product footprint, request for a sample here https://www.factmr.com/connectus/sample?flag=S&rep_id=4042

Spending on eCOA Set to Quadruple

The Fact.MR study opines that though the deployment of clinical trial solutions overshadowed the use of Electronic Clinical Outcome Assessment (eCOA), eSource, and EDA in 2018, the market is envisaged to witness a range of changes during the foreseeable period. Growing penetration of Bring Your Own Device (BYOD) trend in clinical trials is highly likely to pace up the use of eCOAs, such as ePROS, ClinROs, ObsROs, and PerfORs across wide range of pharmaceutical companies and research facilities.

eCOAs is envisaged to hold ~45% of the overall spending share by the end of 2029, in line with the growing use of smartphones and tablets to seamlessly collect clinical data for analysis. Additionally, reduced cost and high scalability of eCOA are the primary determinants that continue to push its adoption during clinical trials, which is envisaged to contribute significantly to the growth of the eCOA, eSource & clinical trials market

For critical insights on this market, request for methodology here https://www.factmr.com/connectus/sample?flag=RM&rep_id=4042

Developed Regions Spearhead in Clinical Trials Deployment Rate

The rapidly advancing healthcare infrastructure, fast internet connectivity, and stringent regulatory product approval framework continue to make North America and Europe a hotbed of opportunities for stakeholders. With an increased number of companies getting cloud based (SaaS) deployment of clinical trial solutions in developed regions, owing to smooth internet connectivity, the market continues to accelerate at a steady pace. Cloud based deployment of digitized solutions accounted for 64% of the overall spending in Europe.

As per the study North America eCOA, eSource & clinical trials spending has been witnessing a steady growth over the years, with the US spending expected to account for ~90% revenue share in the regional eCOA, eSource & clinical trials spending in 2018. In view of the manifold cost and processing benefits of digitization in clinical trials, a larger number of pharmaceutical companies, contract research organizations, and education & research institutions have shifted their focus on paperless approaches. Growing adoption of clinical trial solutions, which contributed ~40% revenue share in North America eCOA, eSource, and clinical trials market, continue to create a window of opportunities of growth for market players.

For in-depth competitive analysis, buy now – https://www.factmr.com/checkout/4042

Fact.MR study provides the long-term outlook of the eCOA, eSource, & clinical trials market for 2019 to 2029. The eCOA, eSource, & clinical trials market is envisaged to register a CAGR of ~14% through 2029.

Chapter 01 – eCOA, eSource & Clinical Trials Market – Executive Summary

The report commences with an executive summary of the eCOA, eSource & Clinical Trials market report, which includes a summary of the key findings and key statistics of the market. It also includes the market spending (US$ million) estimates of the leading segments of the eCOA, eSource & Clinical Trials market and market trends.

Chapter 02 – eCOA, eSource & Clinical Trials Market – Market Introduction

Market introduction comprises detailed market definitions. Readers can find detailed taxonomy and the definitions associated with the eCOA, eSource & Clinical Trials market in this chapter, which will help them gather the basic information about the eCOA, eSource & Clinical Trials market.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Landscape

Wireless Neurostimulator Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028- https://www.factmr.com/report/2188/wireless-neurostimulator-market

Skin Cooling Systems Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028- https://www.factmr.com/report/2186/skin-cooling-systems-market

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Tags ECOA, eSource & Clinical Trials Market, eSource & Clinical Trials Market Analysis, eSource & Clinical Trials Market Demand, eSource & Clinical Trials Market Estimate, eSource & Clinical Trials Market Forecast, eSource & Clinical Trials Market Insights, eSource & Clinical Trials Market Scope, eSource & Clinical Trials Market Share, eSource & Clinical Trials Market Size, eSource & Clinical Trials Market Statistics, eSource & Clinical Trials Market Trends

Pharmaceutical

Rising Focus On Healthcare Propel Demand Of Ventricular Restoration Systems Market

Post author By administrator
Post date October 8, 2021
No Comments on Rising Focus On Healthcare Propel Demand Of Ventricular Restoration Systems Market

In its recently added report by Fact.MR has provided unique insights about Ventricular Restoration Systems Market for the given period. One of the main objectives of this report is to categorize the various dynamics of the market and to offer the latest updates such as mergers and acquisitions, various technological developments, new entrants in the market, which make an impact on different segments.

The comprehensive value chain analysis of the market will assist in attaining better product differentiation, along with a detailed understanding of the core competency of each activity involved. The market attractiveness analysis provided in the report aptly measures the potential value of the market providing business strategists with the latest growth opportunities.

REQUEST A FREE DEMO OF REPORT- https://www.factmr.com/connectus/sample?flag=B&rep_id=5288

Research Coverage

This report segments the functional proteins market based on type, source, form, application and region. In terms of insights, this research report focuses on various levels of analyses—competitive landscape, pricing insights, end-use analysis, and company profiles—which together comprise and discuss the basic views on the emerging & high-growth segments of the functional proteins market, high-growth regions, countries, industry trends, drivers, restraints, opportunities, and challenges.

Critical insights enclosed in the report:

- In-depth assessment of the leading market players in the Ventricular Restoration Systems market
- The regional analysis of the different market segments and sub-segments

- Recent mergers, acquisitions, collaborations, partnerships, and R&D activities.

SWOT analysis of the prominent players in the Ventricular Restoration Systems market
Y-o-Y revenue growth of the Ventricular Restoration Systems market during the forecast period

Ventricular Restoration Systems Market: Key players

Some of the players identified in the Ventricular restoration systems Market include:

Abott
Bioventrix Inc.
Xeltis AG
Neochord Inc.
CryoLife Inc.
Edwards Lifesciences Corp.
CardioKinetics Inc.

Ventricular Restoration Systems Market: Segmentation

Tentatively, the global Ventricular restoration systems Market market has been segmented on the basis of application and end-user.

Based on Application, the global Ventricular restoration systems Market market is segmented as:

Percutaneous ventricular restoration
Surgical ventricular restoration

Based on distribution channel, the global Ventricular restoration systems Market market is segmented as:

Specialty clinics
Hospitals
Ambulatory surgical centers

Ventricular Restoration Systems Market: Drivers

The rise in no. of cardiac cases around the world is the major factor driving the growth of ventricular restoration systems market.

The rising focus on healthcare across various region is another factor that is estimated to propel the growth of the ventricular restoration systems market.

In addition, rising growth in medical tourism in certain developing countries will also contribute towards the growth of the ventricular restoration systems market.

Increasing demand for innovative products and constant R&D activities carried out by the manufacturers to improve the technological aspect in these medical devices will also boost the growth of the ventricular restoration systems market.

The accessibility to different medical coverage for the repayment of cardiovascular medical procedures will also contribute towards the growth of the ventricular restoration systems market.

Reasons to buy this report

To get a comprehensive overview of the Ventricular Restoration Systems market
• To gain wide-ranging information about the top players in this industry, their product portfolio details, and the key strategies adopted by them
• To gain insights about the major countries/regions, in which the Ventricular Restoration Systems market is flourishing

REQUEST FOR CUSTOMIZED REPORT – https://www.factmr.com/connectus/sample?flag=RC&rep_id=5288

Ventricular Restoration Systems Market: Overview

Based on application, the percutaneous ventricular system is expected to experiences considerable growth during the forecast period owing to the minimization of the risk of a more invasive method.

In the end user segment, hospitals will continue to hold the largest share in the ventricular restoration systems market. The no. of cardiac surgeries carried out in the hospital is expected to contribute towards the continued growth of this segment. The effective in-patient and out-patient services may account for a higher market share.

Ventricular Restoration Systems Market: Regional-Wise OutlookGeographically, the Ventricular restoration systems Market market is segmented into seven regions viz. South Asia, East Asia, Europe, Latin America, North America, Oceania and Middle East and Africa.North America is expected to hold the largest market share in the ventricular restoration systems market. This can be attributed towards high demand and adoption of the ventricular restoration systems.

Moreover, this well-established healthcare system along with skilled professional will also serve as one of the major factors leading to the dominance of this region in the global ventricular restoration systems market.

The large R&D investments made by key players in this region to cater to the needs of the population also contributes towards the growth of the ventricular restoration systems market in this region.

Europe is expected to hold the 2nd largest market share owing to rising cardiovascular cases in this region. However, East Asia and South Asia is expected to experience fastest growth in the ventricular restoration systems market.

The exponentially growing medical device industry in this region will lead to considerable growth of the market in this region. In addition, medical tourism in countries like India will further propel the growth of the ventricular restoration systems market in this region.

Why Purchase From Fact.MR?

Customized market reports as per the clients’ requirement
Rich experience in curating market reports for clients from different industrial domains
Round the clock customer service for clients in different time zones
Over 300+ queries addressed every day
Catering to over 700+ clients each year

Explore Fact.MR’s Coverage on the Healthcare Domain:

Leukocyte Count Testing Market – According to the latest research by Fact.MR, the leukocyte count testing market is set to witness exponential growth with over 7%-8% CAGR during 2021-2031. Increasing bacterial infection with the growing adoption of point of care devices will witness a promising growth outlook for leukocyte count testing in the long run.

At-Home Celiac Testing Market – According to the Latest Research by the Fact.MR The Celiac Testing market is set to gain growth in the forecast period 2021-2031 at a CAGR of 8.0%. The Reason for the growth is The increase in prevalence of Celiac disease globally.

Polysaccharide Hemostatic System Market – According to the latest research by Fact.MR, Polysaccharide Hemostatic System market is set to witness a XX% growth during the year 2021-2031.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Visit Our Website: https://www.factmr.com

Pharmaceutical

Transesophageal Echocardiography Demand Grows as CVD Deaths Surpasses 15 million, Scrutinized in the New Analysis

Post author By administrator
Post date October 8, 2021
No Comments on Transesophageal Echocardiography Demand Grows as CVD Deaths Surpasses 15 million, Scrutinized in the New Analysis

Fact.MR – A Market Research and Competitive Intelligence Provider: As per the insights by Fact.MR, the global market for transesophageal echocardiography is projected to grow at a steady CAGR over the assessment period 2021-2031.

Rising prevalence of cardiac and coronary heart diseases is a primary factor supporting the growth of the transesophageal echocardiography market. The market also will gain momentum on account of the increasing number of medical imaging procedures conducted for heart disease diagnosis and treatment.

Also, transesophageal echocardiography has currently emerged as a preferred choice in comparison to traditional systems. It provides high quality images, which, in turn will create a conducive environment for rising adoption of the method.

Besides these, growing healthcare spending coupled with increasing technological advancements are likely to boost the market growth over the forthcoming years.

Effective integration of 3-dimensional (3D) and 4-dimensional (4D) imaging technologies is intended at assisting clinicians to regulate high-grade treatment. These developments will spur sales prospects of the market over the assessment period.

Request a report sample to gain comprehensive insights at

https://www.factmr.com/connectus/sample?flag=B&rep_id=5285

In the coming years, market will witness increasing investments in research and development activities as manufacturers seek to introduce advanced transesophageal echocardiography products.

Regionally, North America will remain a highly lucrative market due to the increasing adoption of new technologies, increasing healthcare spending, and rising awareness regarding the early diagnosis and treatment of cardiac diseases.

Apart from this, increasing patient pool coupled with rapid healthcare advancements will embolden future growth prospects.

Key Takeaways from Transesophageal Echocardiography Market Survey

Driven by advanced healthcare spending, the North America market is anticipated to expand at an impressive CAGR over the forecast period 2021-2031.
Europe market for transesophageal echocardiography is forecast to emerge as a lucrative pocket, exhibiting a healthy CAGR over the forthcoming years.
Asia Pacific market is likely to register fastest growth owing to increasing incidence of heart diseases.
Due to increasing patient pool, India and China market are anticipated to gain significant pace over the assessment period.
Backed by increasing government policies, Brazil market for transesophageal echocardiography is projected to grow at a rapid pace between 2021 and 2031.

Key Drivers

Rising prevalence of cardiac and coronary heart diseases are driving the market growth.
Increasing number of medical surgical procedures are likely to boost the market growth.

Key Restraints

High cost associated with transesophageal echocardiography treatments is expected to hinder the market growth.
The availability of alternative imaging technologies may hamper the market sales.

To gain in-depth insights on Transesophageal Echocardiography Market, request customization at

https://www.factmr.com/connectus/sample?flag=RC&rep_id=5285

Competitive Landscape

Transesophageal echocardiography manufacturers are undertaking acquisitions and collaborations to increase market footprint.

For instance, in 2020, Spacelabs Healthcare, a global producer and designer of patient monitoring and diagnostic cardiology solutions, announced the acquisition of an innovative cloud platform developed by BoxView, LLC. This acquisition of patient and device reporting business strengthens spacelabs digital health portfolio.

In 2021, Hillrom announced the planned acquisition of Bardy Diagnostics, Inc, an innovator in digital health and a leading provider of ambulatory cardiac monitoring technologies.

Some of the leading players operating in the Transesophageal echocardiography market profiled by Fact.MR are:

GE Healthcare
Allengers
Philips Healthcare
Hill-Rom
AliveCor
NIHON KOHDEN
Applied Cardiac Systems
Spacelabs Healthcare
Schiller
AMEDTEC Medizintechnik Aue
Bionym (now Nymi)
CardioComm Solutions
ASPEL
CardioSecur
Cardiac Designs
Bionet
Beurer
Cardioline

More Valuable Insights on Transesophageal Echocardiography Market

Fact.MR, in its new report, offers an unbiased analysis of the global transesophageal echocardiography market, analyzing forecast statistics through 2021 and beyond. The survey reveals growth projections on transesophageal echocardiography market with detailed segmentation:

Based on product type the transesophageal echocardiography (TEE) market can be segmented as

Two-Dimensional (2D)TEE
Three-Dimensional (3D)TEE
Four-Dimensional (4D)TEE

Based on disease type the transesophageal echocardiography (TEE) market can be segmented as

Congenital Heart Disease
Heart Valve Disease
Coronary heart disease
Blood Vessel Disease
Others

Based on end user the transesophageal echocardiography (TEE) market can be segmented as

Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Home Care Settings
Point of Care

Key Questions Covered in the Transesophageal Echocardiography Market Report

The market survey also highlights projected sales growth for transesophageal echocardiography market between 2021 and 2031
The report offers insight into transesophageal echocardiography demand outlook for forecast period 2021-2031
Transesophageal echocardiography market share analysis of the key companies within the industry and coverage of strategies such as mergers & acquisitions, collaborations or partnerships, and others
Transesophageal echocardiography market analysis identifies key growth drivers, restraints, and other forces impacting prevailing trends and evaluation of current market size and forecast and technological advancements within the industry

Explore Fact.MR’s Coverage on the Healthcare Domain:

Polysaccharide Hemostatic System Market – According to the latest research by Fact.MR, Polysaccharide Hemostatic System market is set to witness a XX% growth during the year 2021-2031.

About Fact.MR

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Visit Our Website: https://www.factmr.com

Pharmaceutical

Global Th17 Driven Disease Market Growth banking on Faster Regulatory Approvals for Key Drug Candidates

Post author By administrator
Post date October 8, 2021
No Comments on Global Th17 Driven Disease Market Growth banking on Faster Regulatory Approvals for Key Drug Candidates

Award winning market research company Fact.MR’s ongoing study on the Th17 driven disease treatment market opines that the market is expected to embark on an optimistic growth path through 2021, as the global healthcare industry emerges from the recessionary impacts of the novel coronavirus pandemic.

The market is expected to enjoy robust growth over the coming years. Based on Indication Th17 Driven disease treatment market is classified into Psoriasis, Rheumatoid Arthritis, Multiple Sclerosis, Inflammatory Bowel Disease and Asthma. By the Drug type, Gentamicin, Azathioprine, Calcipotriol, Trolamine salicylate, Histamine and Capsaicin. By distribution channel, hospital pharmacies, is expected to dominate Th17 driven disease treatment market.

North America accounts for a significant revenue share, and is expected to dominate the Th17 driven disease treatment. This is attributed to the increasing prevalence of rheumatoid arthritis, multiple sclerosis, inflammatory bowel disease and asthma. Countries like South Africa, Japan, Brazil, Germany and UK hold a significant market value share. Th17 driven disease treatment market in Asia Pacific is projected to expand at significant growth, driven by rapid regulatory approval for potential drug candidates. Rising government initiatives to increase awareness about the disease is stimulating growth of Th17 Driven disease treatment market.

Request Brochure at https://www.factmr.com/connectus/sample?flag=B&rep_id=5284

Key Takeaways from Fact.MR’s Th17 Driven Disease Market Study

By indication, psoriasis treatment is expected to capture a high market share, amid its rising prevalence
Demand for azathioprine is likely to soar, owing to widespread application in treating rheumatoid arthritis
By distribution channel, hospital pharmacies to remain the primary Th17 driven disease drug suppliers
US to experience high drug sales on the back of surging cases of inflammatory bowel disease
Surging eczema cases to bolster Th17 driven disease drug sales across the UK market
Robust healthcare infrastructure is accelerating inflammatory disease treatment research across Germany
India to experience heightened investments in drug development research, amid rising cases of colitis and Crohn’s disease

Th17 Driven Disease Market- Prominent Drivers

Fast tracking of regulatory approvals of key drug candidates is heightening Th17 driven disease market growth prospects
Availability of multiple treatment alternatives to significantly widen growth prospects
Presence of a robust global supply chain network to accelerate R&D for new drug candidates, stimulating growth

Th17 Driven Disease Market- Key Restraints

Prolonged durations of clinical trials and subsequent waiting list regarding regulatory approvals is restricting growth
Expensive nature of available drugs owing to limited supply is limiting proper sales prospects for the market

Request Customization – https://www.factmr.com/connectus/sample?flag=RC&rep_id=5284

Competitive Landscape

Prominent players in Th17 driven disease treatment market as profiled by Fact.MR’s report are AbbVie, Alexion Pharmaceuticals, Alder Biopharmaceuticals and Astellas Pharma. The aforementioned players are reliant on regulatory approvals for potential drug candidates. In addition, capacity expansion measures, including partnerships, collaborations and acquisitions are also relied upon.

Recently, in April 2021, AbbVie submitted regulatory applications for SKYRIZI^®(risankizumab) for treating Psoriatic Arthritis to the US FDA and the European Medicines Agency (EMA). These submissions are supported by two phase 3 studies in patients with active psoriatic arthritis wherein the drug exhibited improved skin and joint symptoms and physical function.

With regard to acquisitions, UK pharmaceutical giant AstraZeneca announced in December 2020 that it intends to acquire Alexion Pharmaceuticals in order to broad base its scientific presence in immunology, and will also likely heighten the company’s portfolio of Th17 driven diseases treatment in the years to come.

More Insights on the Th17 Driven Disease Market

Fact.MR, in its new offering, brings to fore an unbiased analysis of the global Th17 driven disease market, presenting historical demand data (2016-2020) and forecast statistics for the period, 2021-2031. The study divulges compelling insights on the market based on indication (psoriasis, rheumatoid arthritis, multiple sclerosis, inflammatory bowel disease and asthma), drug (gentamicin, azathioprine, calcipotriol, trolamine salicylate, histamine and capsaicin) and distribution channel (hospital pharmacies, pharmacies and online pharmacies) across eight major regions (North America, Latin America, Western Europe, Eastern Europe, Asia Pacific, China, Japan and Middle East & Africa).

Explore Fact.MR’s Coverage on the Healthcare Domain:

Polysaccharide Hemostatic System Market – According to the latest research by Fact.MR, Polysaccharide Hemostatic System market is set to witness a XX% growth during the year 2021-2031.

About Fact.MR

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Visit Our Website: https://www.factmr.com

Pharmaceutical

Subcutaneous Biologics Market Growth Spurred by Accelerating Cancer and Diabetes Treatment Initiatives: Fact.MR

Post author By administrator
Post date October 8, 2021
No Comments on Subcutaneous Biologics Market Growth Spurred by Accelerating Cancer and Diabetes Treatment Initiatives: Fact.MR

Award winning market research company Fact.MR is currently pursuing a study on the global subcutaneous biologics market. Growth prospects for 2021 and beyond appear significant, with healthcare providers resuming R&D projects which has suffered a setback amidst the coronavirus pandemic crisis.

As per Fact.MR’s analysis, the subcutaneous biologics market stands to gain the maximum from cancer and diabetes drugs development. While the International Diabetes Federation estimates that the number of diabetics shall increase to 578 million people by 2030 from the existing 463 million, the number of cancer patients are likely to rise by over 80% across low-income countries; and 40% in high-income countries (WHO).

Consequently, government entities are fast tracking drug candidate approvals so as to offset this increasing burden. In June 2020, for instance, the US Food & Drug Administration approved Genentech Inc.’s Phesgo (pertuzumab, trastuzumab and hyaluronidase- zzxf) for injection under the skin to treat adult patients with HER-2 positive breast cancer. Likewise, in March 2020, Celltrion announced the launch of its subcutaneous Remsima (infliximab) formulation, which is the only subcutaneous formulation of the Remicade biosimilar for treating rheumatoid arthritis patients.

Request Brochure at https://www.factmr.com/connectus/sample?flag=B&rep_id=5283

The global subcutaneous biologics market is classified based indication, delivery system, distribution channel and region.

Based on the indication, the subcutaneous biologics market is segmented into the following:

Cancer
Crohn’s disease
Cardiovascular disorders
Diabetes
Multiple sclerosis
Psoriasis
Rheumatoid Arthritis
Metabolic disorders
Growth hormone deficiency
Others

Based on the delivery system, the subcutaneous biologics market is segmented into the following:

Syringe
Wearable injector
Automatic injector
Implants
Pen injectors
Others

Based on the distribution channel, the subcutaneous biologics market is segmented into the following:

Hospital pharmacies
Retail pharmacies
Drug stores
Online pharmacies

Subcutaneous Biologics Market- Prominent Drivers

Expanding geriatric population pool and subsequent increase in chronic ailments prevalence to drive future subcutaneous biologics sales
Key manufacturers are targeting the Asia-Pacific region for future growth, attributed to an exponential population surge
Increased research & development funding along with favorable government policies are accelerating subcutaneous biologics research

Subcutaneous Biologics Market- Key Restraints

Documented allergic reactions post-biologics consumption is likely to hinder uptake across key regions
Prolonged waiting durations with respect to regulatory approvals is expected to slow subcutaneous biologics adoption

Discover more about the subcutaneous biologics market on – https://www.factmr.com/report/5283/subcutaneous-biologics-market

Key Takeaways from Fact.MR’s Subcutaneous Biologics Market Study

Subcutaneous biologic drug development for cancers is expected to acquire massive momentum
By delivery system, pen injectors are likely to become the preferred administration route
Rising popularity of home diagnostics compelling high subcutaneous biologics sales through retail pharmacies
Increasing cancer and diabetes incidence stimulating subcutaneous biologics development across the US
UK to experience high growth amid increasing research funding for psoriasis treatment
Conducive government policies to promote biologics and biosimilars development to heighten Germany and France’s growth prospects
India and China to collectively cement their dominance across the Asian market

Competitive Landscape

Prominent subcutaneous biologics market players profiled by Fact.MR include Abbott Laboratories, Pfizer Inc., Genentech Inc., Novartis AG, Biogen Idec, AbbVie Inc, F. Hoffmann-La Roche AG, Genmab A/S, Bristol-Myers Squibb, Eisai Inc., Takeda Pharmaceuticals Ltd., Alnylam Pharmaceuticals, Bayer AG, GlaxoSmithKline, Sanofi SA and Boston Pharmaceuticals among others.

The aforementioned market players rely on regulatory approvals of their product lines in order to enhance their penetration into the market. In March 2021, Genentech’s Actemra became the first biologic therapy approved by the US FDA for slowing the rate of decline in pulmonary function in adults suffering from systemic sclerosis-associated interstitial lung disease.

Likewise, in August 2020, the FDA approved Genmab A/S’s Kesimpta^®(ofatumumab) injection for subcutaneous use to treat relapsing forms of multiple sclerosis (RMS) in adults, to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. Kesimpta is the first B-cell therapy which is suitable for self-administration.

More Insights on the Subcutaneous Biologics Market

Fact.MR, in its new offering, brings to fore an unbiased analysis of the global subcutaneous biologics market, presenting historical demand data (2016-2020) and forecast statistics for the period, 2021-2031. The study divulges compelling insights on the market based on indication (cancer, Crohn’s disease, cardiovascular disorders, diabetes, multiple sclerosis, psoriasis, rheumatoid arthritis, metabolic disorders, growth hormone deficiency and others), delivery system (syringe, wearable injector, automatic injector, implants, pen injectors and others) and distribution channel (hospital pharmacies, retail pharmacies, online pharmacies and drug stores) across seven major regions (North America, Latin America, Europe, South Asia, East Asia, Oceania and Middle East & Africa).

Explore Fact.MR’s Coverage on the Healthcare Domain:

Polysaccharide Hemostatic System Market – According to the latest research by Fact.MR, Polysaccharide Hemostatic System market is set to witness a XX% growth during the year 2021-2031.

About Fact.MR

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Visit Our Website: https://www.factmr.com

Pharmaceutical

External Beam Radiotherapy Segment Is Expected To Register Upsurge Growth In The Global Single Dose Radiotherapy Market

Post author By administrator
Post date October 8, 2021
No Comments on External Beam Radiotherapy Segment Is Expected To Register Upsurge Growth In The Global Single Dose Radiotherapy Market

The latest research report published by Fact.MR on the Single Dose Radiotherapy Market is intended to offer reliable data on various key factors shaping the growth curve of the market. This report works as a rich source of information for key entities such as policy makers, end-use industries, investors, and opinion leaders. The research report published by Fact.MR on the Single Dose Radiotherapy Market provides a detailed overview of the demands and consumptions of various products/services associated with the growth dynamics of the market during the forecast period 2020 to 2030. The in-depth market estimation of various opportunities in the segments is expressed in volumes and revenues. The insights and analytics on the Single Dose Radiotherapy Market span several pages. These are covered in numerous sections, including, drivers and restraints, challenges and opportunities, regional segmentation and opportunity assessment, end-use/application prospects analysis, and competitive landscape assessment.

In addition to understanding the demand patterns of various end users, the report on the Single Dose Radiotherapy Market also enumerates trends expected to attract investments by other various associated industries. The Single Dose Radiotherapy Market report offers detailed assessments and quantitative evaluations that shed light on numerous key aspects that have shaped its evolution over the historical period. In coming years, some of the key aspects that will shape the growth prospects during the forecast period are objectively covered in the study. The following insights and evaluations are worth knowing for any market participant, helping them in ascertaining the prevailing dynamics and the future trajectories of the Single Dose Radiotherapy Market. They are a part of the estimations of the opportunities in various segments.

Request for Brochure – https://www.factmr.com/connectus/sample?flag=B&rep_id=5282

Regional analysis includes

North America (U.S., Canada)
Latin America (Brazil, Mexico, Argentina, Chile, Peru, Rest of LATAM)
EU – (Germany, France, Italy, Spain), UK, BENELUX (Belgium, Netherlands, Luxemburg), NORDIC (Norway, Denmark, Iceland, Sweden), Eastern Europe (Poland, Ukraine, Czech Rep. etc.), Rest of Europe
CIS & Russia
Japan
Asia Pacific Excluding Japan (Greater China, India, S. Korea, ASEAN Countries, Rest of APEJ)
Middle East and Africa (GCC Countries, Turkey, Iran, Israel, South Africa , Rest of MEA)

Single Dose Radiotherapy Market: Segmentation

The international single dose radiotherapy treatment market is segmented based on indication, therapy, end user and region.

By indication, the global single dose radiotherapy market is segmented as:

Breast Cancer
Prostate Cancer
Others

By therapy, the global single dose radiotherapy market is segmented as:

External Beam Radiotherapy
Internal Beam Radiotherapy/Brachytherapy

By end users, the global single dose radiotherapy market is segmented as:

Multi-specialty Hospital
Cancer Clinics

The Report Covers Exhaustive Analysis On:

Market Segments
Market Dynamics
Market Size & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain

Get Access To Research Customization – https://www.factmr.com/connectus/sample?flag=RC&rep_id=5282

Single Dose Radiotherapy Market: Key Players

The key players for the global single dose radiotherapy market Varian Medical Systems, Accuray, Elekta, Ion Beam Applications, IsoRay Medical, ViewRay, Hitachi, Provision Healthcare, Mevion Medical Systems and Panacea Medical Technologies among others.

After reading the market report, readers get insight into:

Major drivers and restraining factors, opportunities and challenges, and the competitive landscape
New, promising avenues in key regions
New revenue streams for all players in emerging markets
Focus and changing role of various regulatory agencies in bolstering new opportunities in various regions
Demand and uptake patterns in key industries of the Single Dose Radiotherapy Market
New research and development projects in new technologies in key regional markets
Changing revenue share and size of key product segments during the forecast period 2020 to 2030
Technologies and business models with disruptive potential

Some important questions that the Single Dose Radiotherapy Market report tries to answer exhaustively are:

Important strategic moves by various players in the global market in recent years with respect to product launches, deals and tie-ups, and mergers and acquisitions, and divestment of shares
Which strategies will enable top players in the Single Dose Radiotherapy Market to expand their geographic footprints?
Which new business models are expected to change the course of growth of key regional markets in near future?
Which technologies will witness most attractive research investments and what will be the key sources of funding for startups and new entrants?
Which products segments have in recent years have seen new, lucrative application areas?

Why Choose Fact.MR?

Deliver updated information on the current industry trends
Available 24/7 to facilitate clients with unbiased solutions
Embrace digital technologies to offer accurate business ideas
Exhaustive supply chain augmentation analysis
Provide reports strictly according to the requirements of the clients

Explore Fact.MR’s Coverage on the Healthcare Domain:

Polysaccharide Hemostatic System Market – According to the latest research by Fact.MR, Polysaccharide Hemostatic System market is set to witness a XX% growth during the year 2021-2031.

About Fact.MR

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Visit Our Website: https://www.factmr.com